Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System – QNT Press Release

SUZHOU, China, Nov. 25, 2022 /PRNewswire/ — inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)), announced today that it has successfully implanted the MonarQ Transcatheter Tricuspid Valve in a 75-year-old female suffering from severe torrential Tricuspid Regurgitation. The Trans-Jugular TTVR procedure was performed on November 21, 2022on compassionate grounds at tthe Heart Centre, Rigshospitalet University Hospital, Copenhagen, Denmarkby interventional cardiologists Prof. Lars Søndergaard, MD, Prof. Ole De Becker MD, and cardiothoracic surgeon Morten Smerup, MD, Jacob Moller MD.(Echocardiographer), Hasse Moeller-Sorensen. MD (Anesthesiologist), along with inQB8 co-founder, Executive Chairman, CMO, and cardiac surgeon, Arshad QuadriMD

“We are grateful to have had the opportunity to work with Dr. Quadri again, along with the team from inQB8, to provide an exciting new treatment option to this patient for whom no other alternatives were available,” said Dr. Lars Søndergaard. ” Due to multiple risk factors and anatomical restrictions, neither traditional tricuspid …

Full story available on

Source link

Recommended For You

About the Author: News Center